0000000001192353

AUTHOR

Virginia Spano'

showing 26 related works from this author

A Convenient Synthesis of Pyrano[2,3-e]isoindol-2-one : a new heteroanalogue of angelicin

2006

researchProduct

4,5,6,9-TETRAHYDROPYRROLO[2',3'-3,4]CYCLOEPTA[1,2-d]ISOSSAZOLE, PROCESS FOR THEIR PRODUCTION AND THEIR USES AS ANTITUMOR AGENTS

2016

The present invention concerns the synthesis of compounds bearing the PYRROLO[2',3'-3,4]CYCLOEPTA[1,2-d]ISOSSAZOLE structure, and their use for the treatment of pathologies having hyperproliferative features included those having neoplastic nature.

CYCLOEPTAISOSSAZOLE ANTITUMOR AGENTSSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Pyrazolo[3,4-h]quinolin-2-ones with photobiological properties

2012

photobiological agents
researchProduct

Pyrazolo[3,4-h]quinolines as potent photosensitizer agents

2013

Pyrazolo[34-h]quinolines
researchProduct

[1,2]oxazole[5,4-e]isoindoles as promising drugs for anticancer chemotherapy

2015

oxazole isoindoles anticancer chemotherapyoxazole isoindoles; anticancer chemotherapyanticancer chemotherapyoxazole isoindoles
researchProduct

Quality characteristic and in vitro digestibility study of barley flour enriched ditalini pasta

2015

barley flour enriched
researchProduct

In vitro digestion of beta glucan enriched pasta: polysaccharide molecular characterization and antioxidant activity of bioaccessible fraction.

2014

pastabeta glucan pasta antioxidantantioxidantbeta glucanbeta glucan; pasta; antioxidant
researchProduct

Novel 1H‑Pyrrolo[2,3‑b]pyridine Derivative Nortopsentin Analogues: Synthesis and Antitumor Activity in Peritoneal Mesothelioma Experimental Models

2013

In this study, we describe the synthesis of new nortopsentin analogues, 1H-pyrrolo[2,3-b]pyridine derivatives and their biological effects in experimental models of diffuse malignant peritoneal mesothelioma (DMPM), a rare and rapidly fatal disease, poorly responsive to conventional therapies. The three most active compounds, 1f (3-[2-(5-fluoro-1-methyl-1H-indol-3- yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridine), 3f (3-[2-(1H-indol-3-yl)-1,3- thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine), and 1l (3-[2-(5-fluoro-1- methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b] pyridine), which were shown to act as cyclin-dependent kinase 1 inhibitors, consistently reduced DMPM cell p…

CDK1 inhibitorsmalignant peritoneal mesothelioma3‑b]pyridineNortopsentin Analogues1H‑Pyrrolo[21H‑Pyrrolo[23‑b]pyridineCDK1 inhibitorsNortopsentin AnalogueSettore CHIM/08 - Chimica Farmaceuticamalignant peritoneal mesothelioma; 1H‑Pyrrolo[2; 3‑b]pyridine; Nortopsentin Analogues; CDK1 inhibitors
researchProduct

Synthesis and antitumor activity of new 7-azaindole derivative nortopsentin analogues

2016

nortopsentin analoguesSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Isoxazolo[5,4-e]isoindole a new ring system with potent antitumor activity

2011

4-e]isoindoleIsoxazolo[5; 4-e]isoindole; Combretastatin; antitumor agentsCombretastatinIsoxazolo[5antitumor agentsIsoxazolo[54-e]isoindole Combretastatin antitumor agents
researchProduct

Biological evaluation of Pyrrolo[3,4-h]quinazolines

2012

Pyrrolo[34-h]quinazolines
researchProduct

Pirazolo[3,4-h]chinoline come nuova classe di agenti fotosensibilizzanti

2013

Pirazolo[34-h]chinoline
researchProduct

Composti a struttura ossazolica, procedimenti per la loro produzione e loro impiego per la cura di patologie a carattere iperproliferativo

2017

La presente invenzione riguarda composti che presentano nella loro struttura il sistema eterociclico [1,2]Ossazolo[5,4-e]isoindolo, un procedimento per la oro produzione e il loro impiego per la cura di patologie a carattere iperproliferativo comprese quelle di natura neoplastica. I nuovi derivati saggiati al National Cancer Institute di Bethesda su un 60 linee cellulari umane divise in 9 sottopannelli (mammella, ovaie, polmone, colon, SNC, melanoma, leucemia, rene, prostata), hanno mostrato attività antiproliferativa da micro a nanomolare, rivelando alcuni derivati particolarmente promettenti.

[12]Ossazolo]isoindoli agenti antitumoraliSettore CHIM/08 - Chimica Farmaceutica
researchProduct

2-substituted-[1,3]thiazolo[4,5-e]isoindoles as kinases inhibiting compounds

2013

kinases inhibitors
researchProduct

SYNTHESIS AND PHOTOBIOLOGICAL ACTIVITY OF PYRROLO-FUSED HETEROCYCLES

2008

PHOTOBIOLOGICA ACTIVITYSettore CHIM/08 - Chimica FarmaceuticaPYRROLO-FUSED HETEROCYCLES
researchProduct

4,5,6,9-tetraidropirrolo[2',3':3,4] cicloepta[1,2-d] isossazoli, procedimento per la loro produzione e loro uso come antitumorali

2016

La presente invenzione riguarda derivati a struttura 4,5,6,9- tetraidropirrolo[2',3':3,4]cicloepta[1,2-d]isossazolica, procedimenti per la loro produzione e il loro uso per la cura di patologie a carattere iperproliferativo comprese quelle di natura neoplastica. I nuovi derivati saggiati al National Cancer Institute di Bethesda su un pannello di circa 60 linee cellulari umane divise in 9 sottopannelli (mammella, ovaie, polmone, colon, SNC, melanoma, leucemia, rene, prostata), hanno mostrato attività antiproliferativa da micro a nanomolare, rivelando alcuni derivati particolarmente promettenti

cicloeptaisossazoli agenti antitumoraliSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Editorial: Emerging heterocycles as bioactive compounds

2023

Heterocycles represent a privileged scaffold due to their ability to interact with biological systems via heteroatoms. It is no coincidence that every year the Food and Drug Administration approves numerous new drugs that contain at least one heterocyclic system as active pharmacophoric part in their structure. Many heterocyclic compounds with therapeutic properties, including anticancer, antimicrobial, anti-inflammatory and so on, come from natural sources such as plants and animals, and medicinal chemists very often use them to study their chemical space and improve their biological activity. In fact, several efficient approaches for the formation of aromatic heterocyclic compounds and th…

heterocycles new chemical entities natural products purine nucleoside phosphorylase pantetheinase sulfhydrylase activity quinazolineGeneral ChemistrySettore CHIM/08 - Chimica FarmaceuticaFrontiers in Chemistry
researchProduct

PYRANO[2,3-E]ISOINDOL-2-ONE: A NEW RING SYSTEM WITH POTENTIAL PHOTOBIOLOGICAL PROPERTIES

2006

researchProduct

PYRROLO[3,4-H]QUINAZOLINES WITH ANTITUMOR ACTIVITY

2010

QUINAZOLINESettore CHIM/08 - Chimica FarmaceuticaQUINAZOLINE; ANTITUMOR ACTIVITYANTITUMOR ACTIVITY
researchProduct

SINTESI DI NUOVI DERIVATI[2,3-E]ISOINDOL-2-ONI A POTENZIALE ATTIVITA' FOTOCHEMIOTERAPICA

2007

researchProduct

Pyrrolo-fused heterocycles as photochemotherapeutic agents

2008

Photochemioterapeutic agents
researchProduct

New topoisomerase I inhibitors with condensed-azaindole structure

2012

topoisomerasi I inhibitors
researchProduct

In vitro digestion of beta glucan enriched pasta and antioxidant potential of digesta

2014

beta glucan
researchProduct

NUOVI COMPOSTI PIRAZOLO[3,4-H]CHINOLINICI, LORO PREPARAZIONE ED USO MEDICO

2016

La presente invenzione si riferisce al campo dei composti pirazolo[3,4-h]chinolinici, loro preparazione ed uso medico, in particolare per la cura di patologie a carattere iperproliferativo comprese quelle di natura neoplastica.

PIRAZOLO[34-h]CHINOLINE AGENTI ANITUMORALISettore CHIM/08 - Chimica Farmaceutica
researchProduct

ISOXAZOLO[5,4-E]ISOINDOLE: A NEW RING SYSTEM WITH POTETIAL PHOTOBIOLOGICAL PROPERTIES

2008

ISOXAZOLO[54-E]ISOINDOLESettore CHIM/08 - Chimica Farmaceutica
researchProduct

Pyrrolocycloheptaoxazole as potent antitumor agents

2016

Pyrrolocycloheptaoxazole
researchProduct